Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

Pedestrian Killed in Crash on 5 Freeway Near 710 Freeway


Victim Hit by Car in Fatal Los Angeles Accident 

Fatal Accident 6

Los Angeles, CA (February 23, 2020) – A pedestrian was killed in a crash in Los Angeles. The fatal accident occurred on the morning of February 23 on the 5 Freeway.

A pedestrian was hit by a vehicle on the southbound 5 Freeway, near the southbound 710 Freeway. The pedestrian died from their injuries.

Our heartfelt condolences go out to the friends and loved ones of the victim.

#Los Angeles

#90022


November 22, 2019

Crash on Dogwood Road Causes Minor Injuries

2 Vehicles Involved in Brawley Accident...


December 27, 2019

Crash at 405 Freeway and Wilmington Avenue Causes Minor Injuries

5 Vehicles Involved in Carson Accident...


May 28, 2020

Man Killed in Pedestrian Crash at State Route 76 and College Boulevard

Victim Hit by Car in Fatal Oceanside Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.